These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 2969

  • 1. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC, Berthold S, Schlumpf E, Keller H, Riva G.
    Schweiz Med Wochenschr; 1975 Jul 05; 105(27):863-72. PubMed ID: 2969
    [Abstract] [Full Text] [Related]

  • 2. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN, Alaupovic P.
    Gastroenterology; 1976 Jul 05; 71(1):87-93. PubMed ID: 179911
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P, Böttcher J, Maschek H, Selberg O, Müller MJ.
    Hepatology; 1998 Nov 05; 28(5):1199-205. PubMed ID: 9794902
    [Abstract] [Full Text] [Related]

  • 4. [The significance of lipoprotein X in the diagnosis of obstructive jaundice: comparison with other biochemical tests (author's transl)].
    Mayr K.
    Dtsch Med Wochenschr; 1975 Oct 24; 100(43):2193-7. PubMed ID: 240665
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic efficacy of serum alkaline phosphatase and gamma-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980-1990).
    Center SA, Slater MR, Manwarren T, Prymak K.
    J Am Vet Med Assoc; 1992 Oct 15; 201(8):1258-64. PubMed ID: 1358870
    [Abstract] [Full Text] [Related]

  • 6. [Value of congestive enzymes in liver and biliary tract diseases].
    Peters JE, Otto L, Gründig CA, Nilius R, Zipprich B, Eismann R, Busse HJ, Thulin H, Müller G.
    Z Gesamte Inn Med; 1973 Sep 15; 28(18):Suppl:273-6. PubMed ID: 4148804
    [No Abstract] [Full Text] [Related]

  • 7. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B, Palynyczko Z.
    Pol Med Sci Hist Bull (1973); 1975 Sep 15; 15(5-6):551-5. PubMed ID: 1228704
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
    Palynyczko Z, Milewski B.
    Mater Med Pol; 1975 Sep 15; 7(4):327-33. PubMed ID: 175222
    [Abstract] [Full Text] [Related]

  • 9. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S.
    Scand J Gastroenterol; 1975 Sep 15; 10(1):5-15. PubMed ID: 164686
    [Abstract] [Full Text] [Related]

  • 10. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D.
    Wien Klin Wochenschr Suppl; 1977 Sep 15; 69():3-28. PubMed ID: 266315
    [Abstract] [Full Text] [Related]

  • 11. [LP-X in the first month of life (author's transl)].
    Lachmann D, Eder G.
    Padiatr Padol; 1977 Sep 15; 12(4):334-8. PubMed ID: 904943
    [Abstract] [Full Text] [Related]

  • 12. [The diagnostic importance of low-density lipoprotein (LP-X) for the diagnosis of cholestasis].
    Michel B, Ritter U.
    Z Gastroenterol; 1976 Sep 15; 14(5):556-64. PubMed ID: 184610
    [Abstract] [Full Text] [Related]

  • 13. [LP-X in newborns: increased incidence of positive tests without cholestasis (author's transl)].
    Witt I, Ober M.
    J Clin Chem Clin Biochem; 1976 Apr 15; 14(4):197-202. PubMed ID: 5573
    [Abstract] [Full Text] [Related]

  • 14. [Changes in hepatobiliary enzymes and its isoenzymes in intrahepatic cholestasis in pregnancy].
    Chen Y.
    Zhonghua Fu Chan Ke Za Zhi; 1991 Mar 15; 26(2):82-5, 123-4. PubMed ID: 1677617
    [Abstract] [Full Text] [Related]

  • 15. [Serum 5-nucleotidase activity in chronic hepatobiliary diseases].
    Dinkov L, Kraĭnikova M, Brailski Kh.
    Vutr Boles; 1979 Mar 15; 18(1):39-46. PubMed ID: 34931
    [Abstract] [Full Text] [Related]

  • 16. Lipoprotein-X and other tests in the diagnosis of obstructive jaundice in the infant.
    Lipsitz PJ, Yoss B, Schussheim A.
    Am J Gastroenterol; 1979 Jan 15; 71(1):95-100. PubMed ID: 86296
    [Abstract] [Full Text] [Related]

  • 17. [Determination of serum lipoprotein-X (LP-X) and gamma-glutamyl transpeptidase (gamma GT); its use in the differential diagnosis of hepatobiliary diseases].
    Alegre B, Martínez M, Bretó M, García AM, Cabades F, Berenguer J.
    Rev Esp Enferm Apar Dig; 1977 Jun 15; 50(6):641-6. PubMed ID: 19816
    [No Abstract] [Full Text] [Related]

  • 18. [The diagnosis of cholestasis: lipoprotein X (LP-X) (author's transl)].
    Fischer M, Falkensammer C, Barouch G, Wuketich S, Kromberger O, Schnack H.
    Wien Klin Wochenschr; 1975 Sep 05; 87(16):524-31. PubMed ID: 5812
    [Abstract] [Full Text] [Related]

  • 19. Quantitative changes of serum lipoprotein-X after cholestyramine administration in infants with cholestatic biliary tract and liver disease.
    Poley JR, Caplan DB, Magnani HN, Alaupovic P, Smith EI, Campbell DP, Bhatia M, Burdelski M, Bojanovski D.
    Eur J Clin Invest; 1978 Dec 05; 8(6):397-404. PubMed ID: 105912
    [Abstract] [Full Text] [Related]

  • 20. [The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy].
    Kaulhausen H, Pfeiffer P, Breuer H.
    Z Klin Chem Klin Biochem; 1972 Feb 05; 10(2):51-5. PubMed ID: 4347073
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.